AVROBIO Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Author's Avatar
Jul 08, 2021

AVROBIO%2C+Inc. (Nasdaq: AVRO), a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic disease, today announced that the company has granted non-statutory stock options for the purchase of up to an aggregate of 14,500 shares of the company’s common stock to two new employees as inducement awards under the company’s 2019 Inducement Plan. The grants were made in accordance with Nasdaq Listing Rule 5635(c)(4).